Insights On Solid Dose Manufacturing

  1. Developing And Manufacturing Drugs With HPAPIs 1/27/2025

    Learn why companies must invest in specialized expertise to develop scalable, safe, and efficient manufacturing processes for highly potent oral solid dose products.

  2. Future Of Pharma Packaging: Trends, Tech, And Patient Solutions 9/25/2025

    Explore how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes.

  3. Functional Release Multiparticulates Slam 7/17/2024

    Review Adare Pharma Solutions’ innovative technologies and learn how these capabilities can improve patient outcomes and improve manufacturing efficiency.

  4. NanoImprove The Performance Of Your Formulations 9/24/2024

    Learn how Nanoforming can help improve the performance of your molecule by increasing drug loads, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation.

  5. Round Tablet Compression Tooling — To Key Or Not To Key The Punches 7/30/2024

    What makes the keying in tablet compression tooling, specifically in tablet punches, so important to the tablet manufacturing processes?

  6. Developing And Manufacturing Minitablets To Extend Drug Lifecycle 1/27/2025

    Pharmaceutical companies should leverage oral minitablets to extend drug lifecycles, optimize dosing, and improve patient-centric solutions while overcoming manufacturing challenges.

  7. Integration From Formulation Development To Manufacturing, Packaging 2/27/2025

    Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.

  8. Seizing Market Share Pre-Patent Expiry: The Evolution Of A CDMO Partnership In Navigating A Paragraph IV ANDA Submission 6/26/2024

    The dynamic pharmaceutical landscape demands agility and strategic foresight. Explore how leveraging a key partnership helped to overcome a looming patent expiry for a second-generation acne medication.

  9. Liquid Suspension Trends In The CDMO Space 1/15/2026

    Liquid suspension formulations are rapidly growing in pharma, driven by patient needs, formulation advances, and CDMO innovation. 

  10. Closing The Duration Gap In FDA-Approved Long-Acting Contraceptives 7/17/2024

    A gap exists between three months and three years in FDA-approved long-acting contraceptives (LACs). A microsphere formulation enables sustained release over a six to twelve-month period.